Lanean...
ExRNA in Biofluids as Biomarkers for Brain Tumors
Patients with high-grade gliomas and glioblastomas (GBMs) have poor survival despite optimal surgical and drug therapy. Minimally invasive diagnostic biomarkers would enable early diagnosis and tumor-specific treatments for ‘personalized targeted’ therapy, and would create the basis for response tra...
Gorde:
| Argitaratua izan da: | Cell Mol Neurobiol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451268/ https://ncbi.nlm.nih.gov/pubmed/26993514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10571-015-0284-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|